NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that Stephen Willard, J.D., Chief Executive Officer and Dr.

The companies will demonstrate the BackBox platform at Infosecurity Europe 2023 LONDON and DALLAS, June 20, 2023 /PRNewswire/ -- CMS Distribution, a value-added IT distribution company serving...

Centrical, a category-leading, global software as a service company, releases Employee Performance Experience at Customer Contact Week in Las Vegas. Today, frontline employees expect "more...

Hips – and toys – don't lie, the excitement is growing for the Toy of the Year® (TOTY®) Awards, hosted by The Toy Foundation™ (TTF). Taking place Friday, September 29 at Cipriani's 42nd...

Full SURMOUNT-2 phase 3 data on the efficacy and safety of tirzepatide for chronic weight management in adults with obesity or overweight and type 2 diabetes New phase 2 data for retatrutide and...